Some specialized forms (liposomal glutathione, sublingual sprays) absorb better than basic oral glutathione, but still less than IV
Glutathione targets melanin production at source
The study proposed that early lysosomal failure within dystrophic neurites promotes continued amyloid plaque accumulation and microglia recruitment in AD (Sharoar et al., 2021)
Its presence at 50mg makes it the primary driver of skin-focused research outcomes within this blend
Assuming you meet the clinical criteria for GLP-1 therapy (BMI of 30+, or 27+ with a related health condition), Hers may be a strong fit depending on your priorities
Ideal candidates for leading with NAD+: Patients over 40 experiencing persistent fatigue that does not resolve with sleep or lifestyle changes Individuals with metabolic syndrome, insulin resistance, or difficulty managing weight despite dietary effort Patients recovering from substance use, where NAD+ IV therapy has shown measurable benefit in reducing withdrawal symptoms and cravings High-performance athletes or executives seeking cognitive edge and faster physical recovery Patients with early neurodegenerative concerns who want evidence-supported mitochondrial support GHK-Cu Dosage and NAD+ Dosage: What Clinical Protocols Actually Use Dosing varies based on delivery route, patient body weight, and clinical goal
.webp)
